SCHEMBL5465705

SCHEMBL5465705

COc1ccc(CNn2nnc3c(Cl)ncnc32)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
LMNA P02545 4/20 0.47
TP53 P04637 3/20 0.46
MAPT P10636 7/20 0.44
RXFP1 Q9HBX9 1/20 0.44
CCNB2 O95067 1/20 0.43
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43
CCNB3 Q8WWL7 1/20 0.43
HPGD P15428 3/20 0.41
CCNE2 O96020 1/20 0.41
CCNE1 P24864 1/20 0.41
CDK2 P24941 1/20 0.41
THRB P10828 1/20 0.40
KDM4E B2RXH2 2/20 0.40
HTT P42858 1/20 0.40
PDE5A O76074 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
ADORA2A P29274 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4928309 0.80 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2LMNATP53MAPT
SCHEMBL5466193 0.78 ADORA2A (0.45) ALDH1A1SMN1; SMN2LMNATP53MAPT
SCHEMBL5465357 0.70 HPGD (0.64) ALDH1A1SMN1; SMN2LMNAHPGD
SCHEMBL5452386 0.69 ALDH1A1 (0.51) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
SCHEMBL5451833 0.68 PDE10A (0.61) ALDH1A1SMN1; SMN2LMNATP53MAPT
SCHEMBL30899543 0.68 SMN1; SMN2 (0.53) ALDH1A1SMN1; SMN2LMNATP53MAPT
SCHEMBL5460397 0.68 ABL1 (0.57) ALDH1A1SMN1; SMN2LMNATP53MAPT
SCHEMBL17283025 0.68 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
SCHEMBL5452368 0.68 ADORA2A (0.51) ALDH1A1SMN1; SMN2LMNAMAPTHPGD
SCHEMBL6078154 0.67 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2LMNAMAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070203159-A1 Purine compounds UNIVERSITETET I OLSO (NO) 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203159-A1 Purine compounds PNP, UMPS, TYMP ALDH1A1 2044/4885SMN1; SMN2 3727/4885LMNA 2001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.